Skip to main content
logo
Racura Oncology Ltd (ASX:RAC)
Australia flag Australia · Delayed Price · Currency is AUD
2.150
-0.100 (-4.44%)
Aug 28, 2026, 4:10 PM AEST

Racura Oncology Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
2.812.815.2543.130.71
Revenue Growth
0%-46.49%31.25%27.73%342.83%82.71%
Gross Profit
1.721.724.621.391.11-0.28
Operating Income
-10.4-10.4-5.5-14.48-10.48-11.2
Net Income
-11.09-11.09-4.79-13.82-9.92-11.2
Earnings Per Share
-0.06-0.06-0.03-0.08-0.06-0.07
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
34.2934.2913.6717.1921.5233.54
Total Debt
------
Net Cash (Debt)
34.2934.2913.6717.1921.5233.54
Net Cash Growth
63.73%150.92%-20.50%-20.13%-35.84%259.79%
Net Cash Per Share
0.190.190.080.100.130.22

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-8.25-8.25-4.57-9.55-10.65-6.26
Capital Expenditures
-0-0----
Free Cash Flow
-8.25-8.25-4.57-9.55-10.65-6.26
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
61.23%61.23%87.91%34.72%35.35%-39.91%
Operating Margin
-369.99%-369.99%-104.74%-361.80%-334.22%-1582.76%
Pretax Margin
-394.38%-394.38%-91.11%-345.18%-316.60%-1582.63%
Profit Margin
-394.38%-394.38%-91.11%-345.18%-316.60%-1582.63%
FCF Margin
-293.44%-293.44%-87.06%-238.43%-339.83%-884.12%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
156.91154.4138.8577.6363.73439.48